Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-13 5:20 pm Purchase | 2023-12-08 | 13G | Finch Therapeutics Group, Inc. FNCH | Ugwumba Chidozie | 160,366 9.990% | 43,699 (+37.46%) | Filing History |
| 2022-02-14 3:59 pm Sale | 2021-12-31 | 13G | Finch Therapeutics Group, Inc. FNCH | Walton Thomas Layton | 0 0.000% | -116,239 (Position Closed) | Filing History |
| 2022-02-14 3:46 pm Purchase | 2021-12-31 | 13G | Finch Therapeutics Group, Inc. FNCH | Ugwumba Chidozie | 116,667 7.370% | 116,667 (New Position) | Filing History |
| 2021-04-01 5:22 pm Purchase | 2021-03-23 | 13D | Finch Therapeutics Group, Inc. FNCH | Crestovo Investor LLC | 421,381 26.800% | 421,381 (New Position) | Filing History |
| 2021-03-29 4:41 pm Purchase | 2021-03-19 | 13D | Finch Therapeutics Group, Inc. FNCH | Haft Nicholas | 133,102 8.500% | 133,102 (New Position) | Filing History |
| 2021-03-26 4:47 pm Purchase | 2021-03-23 | 13G | Finch Therapeutics Group, Inc. FNCH | Walton Thomas Layton | 116,239 7.400% | 116,239 (New Position) | Filing History |